August 24, 2021
August 24, 2021 —
After more than 50 days on advanced life support, a multi-disciplinary team at UC San Diego Health helps a patient who contracted COVID-19 become a candidate for a successful double lung transplant. The transplant surgery was the first in the region performed on a COVID-19 patient.
August 24, 2021
August 24, 2021 —
Among adolescents ages 10 to 14 in the U.S, the overall rate of drug use remained relatively stable in the first six months of the COVID-19 pandemic. However, one change was a decreased use of alcohol, but an increased use of nicotine and misuse of prescription drugs.
August 19, 2021
August 19, 2021 —
New visualizations of SARS-CoV-2 have allowed researchers to discover how the virus enters and infects healthy human cells. They found that glycan sugar molecules act as infection “gates” to our cell’s receptors.
August 18, 2021
August 18, 2021 —
In fiscal year 2021 (July 1-June 30), UC San Diego earned $1.54 billion in sponsored research funding, a 6% increase over the previous year. This is the largest number ever for the university and marks the 12th consecutive year the campus has earned more than $1 billion in funding to support its ext
August 11, 2021
August 11, 2021 —
Part of UC San Diego’s Return to Learn program, wastewater screening helped prevent outbreaks by detecting 85 percent of cases early, allowing for timely testing, contact tracing and isolation.
August 9, 2021
August 9, 2021 —
UC San Diego Health physicians describe first known case of young, healthy adult experiencing central nervous system inflammation due to COVID-19, but without cognitive impairment.
August 5, 2021
August 5, 2021 —
UC San Diego researchers report that solid organ transplant recipients who were vaccinated experienced an almost 80 percent reduction in the incidence of symptomatic COVID-19 compared to unvaccinated counterparts during the same time.
August 4, 2021
August 4, 2021 —
“When will we get ‘back to normal?’” is a question looming on many Americans’ minds. The answer largely depends on the country’s ability to substantially ramp up immunity to SARS CoV-2.
August 2, 2021
August 2, 2021 —
UC San Diego researchers modify remdesivir, creating oral version that can be taken earlier in COVID-19 diagnoses. In cell and animal studies, revised drug proved effective and safe.
July 16, 2021
July 16, 2021 —
Researchers at UC San Diego School of Medicine and Rady Children’s Institute for Genomic Medicine have produced a stem cell model that demonstrates a potential route of entry of SARS-CoV-2, the virus that causes COVID-19, into the human brain.
